Cargando…
Nanoparticulate systems as drug carriers: the need
Development of nanoparticles for drug delivery has progressed by leaps and bounds over the last few decades, facilitating the possibility of an efficacious therapy for some fatal diseases. This development has stemmed from either the unsuitable physicochemical characteristics of the existing drug mo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152047/ http://dx.doi.org/10.1533/9781908818195.1 |
_version_ | 1783521389850918912 |
---|---|
author | Patravale, Vandana Dandekar, Prajakta Jain, Ratnesh |
author_facet | Patravale, Vandana Dandekar, Prajakta Jain, Ratnesh |
author_sort | Patravale, Vandana |
collection | PubMed |
description | Development of nanoparticles for drug delivery has progressed by leaps and bounds over the last few decades, facilitating the possibility of an efficacious therapy for some fatal diseases. This development has stemmed from either the unsuitable physicochemical characteristics of the existing drug molecules, such as limited solubility and hence poor bioavailability, or the inadequacy of the conventional delivery systems to provide safe and efficient delivery. This chapter focuses on the precise need for the development of these novel nanoparticulate drug carriers and reasons for their popularity with the drug delivery scientists. The text also discusses the various strategies, including different formulation and targeting approaches, which have been adopted to overcome the challenges presented by the inherent properties of the drug molecules. Examples of nanoparticulate drug delivery systems which have already gained market approval have been cited in the discussion, wherever applicable. |
format | Online Article Text |
id | pubmed-7152047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71520472020-04-13 Nanoparticulate systems as drug carriers: the need Patravale, Vandana Dandekar, Prajakta Jain, Ratnesh Nanoparticulate Drug Delivery Article Development of nanoparticles for drug delivery has progressed by leaps and bounds over the last few decades, facilitating the possibility of an efficacious therapy for some fatal diseases. This development has stemmed from either the unsuitable physicochemical characteristics of the existing drug molecules, such as limited solubility and hence poor bioavailability, or the inadequacy of the conventional delivery systems to provide safe and efficient delivery. This chapter focuses on the precise need for the development of these novel nanoparticulate drug carriers and reasons for their popularity with the drug delivery scientists. The text also discusses the various strategies, including different formulation and targeting approaches, which have been adopted to overcome the challenges presented by the inherent properties of the drug molecules. Examples of nanoparticulate drug delivery systems which have already gained market approval have been cited in the discussion, wherever applicable. 2012 2014-03-27 /pmc/articles/PMC7152047/ http://dx.doi.org/10.1533/9781908818195.1 Text en Copyright © 2012 V. Patravale, P. Dandekar and R. Jain. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Patravale, Vandana Dandekar, Prajakta Jain, Ratnesh Nanoparticulate systems as drug carriers: the need |
title | Nanoparticulate systems as drug carriers: the need |
title_full | Nanoparticulate systems as drug carriers: the need |
title_fullStr | Nanoparticulate systems as drug carriers: the need |
title_full_unstemmed | Nanoparticulate systems as drug carriers: the need |
title_short | Nanoparticulate systems as drug carriers: the need |
title_sort | nanoparticulate systems as drug carriers: the need |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152047/ http://dx.doi.org/10.1533/9781908818195.1 |
work_keys_str_mv | AT patravalevandana nanoparticulatesystemsasdrugcarrierstheneed AT dandekarprajakta nanoparticulatesystemsasdrugcarrierstheneed AT jainratnesh nanoparticulatesystemsasdrugcarrierstheneed |